QTNT

Quotient Limited

Price

return (12m)

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

QTNT price

Quotient

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment QTNT

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals QTNT

Valuation

P/E

0.00

Sector -3.50

Industry -3.50

P/BV

0.00

Sector 2.01

Industry 2.01

P/Revenue (PSR)

Sector 2.01

Industry 2.01

EV/EBITDA

-46.04

Sector -223.67

Industry -223.67

EV/EBIT

-36.07

Sector -47.92

Industry -47.92

P/EBITDA

Sector -21.50

Industry -21.50

P/EBIT

Sector -28.21

Industry -28.21

P/Total Assets

Sector 1.19

Industry 1.19

P/Net Current Assets

Sector -10.26

Industry -10.26

P/Working Capital

Sector -167.98

Industry -167.98

EPS

-29.18

Sector -1.79

Industry -1.79

BVPS

-49.14

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

2.12%

Sector 41.30%

Industry 41.30%

EBITDA Margin

-49.83%

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

-63.60%

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

86.06%

Sector -35.21%

Industry -35.21%

Net Profit Margins

-100.00%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.08

Sector 0.02

Industry 0.02

Profitability

ROE

59.38%

Sector -56.67%

Industry -56.67%

ROA

-103.94%

Sector -59.91%

Industry -59.91%

ROIC

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 2.89

Industry 2.89

Net Debt / EBITDA

-46.04

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

-36.07

Sector -8.06

Industry -8.06

Net Debt / Equity

-1.09

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

-1.15

Sector -0.85

Industry -0.85

Equity/Assets

-1.75

Sector 0.46

Industry 0.46

Liabilities/Assets

2.75

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

-0.50%

Sector -

Industry -

5Y Earnings CAGR

-3.57%

Sector -

Industry -

Fundamentals QTNT

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
QTNT Quotient Limited	$0.00	-	0.00%	0.00	0.00	59.38%	-100.00%
JNJ Johnson & Johnson	$269.99	56.71%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.66	23.21%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$263.96	22.44%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.24	-26.07%	4.29%	10.56	5.61	53.11%	35.32%
MRK Merck & Co. Inc.	$146.87	87.26%	2.31%	113.21	8.55	7.55%	4.76%
AZN AstraZeneca PLC	$166.08	10.74%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$63.06	48.20%	4.04%	13.67	5.68	41.55%	18.85%
ZTS Zoetis Inc.	$71.40	-50.11%	2.88%	11.47	9.64	84.02%	27.77%
AMGN Amgen Inc.	$385.65	38.85%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$784.85	33.10%	0.47%	18.63	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$112.45	44.52%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$874.65	25.89%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$508.34	32.68%	0.00%	29.15	6.34	21.76%	35.00%
CAH Cardinal Health Inc.	$225.38	52.58%	0.91%	30.53	-19.32	-63.29%	0.68%
ARGX argenx SE	$990.32	34.42%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$42.02	29.13%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

QTNT Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Quotient

Quotient Limited

Average Investor10 user rating

4.0 (0 people)

United States

14 years

Founded: 2012

2014

Time since IPO - 12 years

182

Employees

Quotient Limited (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $-208.89 million.

The company employs approximately 182 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Quotient Limited reported $37.41 million in revenue, generating net income of $-124.03 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker QTNT.

Market cap

Net worth

$-208.89 million

$-208,885,000.00

Assets

$119.33 million

$119,326,000.00

Total Shares Outstanding

4.25 million

4,250,000

Average Daily Trading Volume

$1.84 million

$1,837,549.06

Sector

Health Care

Industry

Biotechnology

QTNT

QTNT revenue and profits

Financial Results QTNT

DRAG THE FRAME TO SEE MORE DATA

QTNT cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$874.65 25,89% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$225.38 52,58% (12M)

P/E

30.53

0.91%

ROE

-63.29%

P/BV

-19.32

JNJ - Johnson & Johnson

$269.99 56,71% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$263.96 22,44% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$146.87 87,26% (12M)

P/E

113.21

2.31%

ROE

7.55%

P/BV

8.55

AZN - AstraZeneca

$166.08 9,00% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.66 23,21% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$874.65 25,89% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$225.38 52,58% (12 M)

P/L

30.53

0.91%

ROE

-63.29%

P/VP

-19.32

JNJ - Johnson & Johnson

$269.99 56,71% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$263.96 22,44% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$146.87 87,26% (12 M)

P/L

113.21

2.31%

ROE

7.55%

P/VP

8.55

AZN - AstraZeneca

$166.08 9,00% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.66 23,21% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Quotient (QTNT) today?

A cotação de Quotient (QTNT) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de Quotient (QTNT) iniciou o ano negociando na casa dos US$ 0.00 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Quotient (QTNT) e dados de ações do Ibovespa e mercados internacionais.

Quando Quotient (QTNT) paga dividendos?

Quotient (QTNT) não distribuiu dividendos no último ano.

Is Quotient (QTNT) a good investment?

Atualmente, Quotient (QTNT) está cotada a US$ 0.00, com um P/L de 0.00, representando um desvio de 0% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Quotient (QTNT) stock?

Investir em ações de Quotient (QTNT) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Quotient (QTNT) yield today?

A rentabilidade de Quotient (QTNT) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Quotient (QTNT) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

QTNT

Quotient Limited

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment QTNT

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING QTNT WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Quotient

Quotient Limited

United States

14 years

2014

182

PROFIT X PRICE QTNT

Financial Results QTNT

QTNT cash flow

Asset, Revenue and Profit Growth - QTNT

QTNT balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions